TY - JOUR
T1 - Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
AU - Nakamura, Ryoichi
AU - Atsuta, Naoki
AU - Watanabe, Hazuki
AU - Hirakawa, Akihiro
AU - Watanabe, Hirohisa
AU - Ito, Mizuki
AU - Senda, Jo
AU - Katsuno, Masahisa
AU - Tanaka, Fumiaki
AU - Izumi, Yuishin
AU - Morita, Mitsuya
AU - Ogaki, Kotaro
AU - Taniguchi, Akira
AU - Aiba, Ikuko
AU - Mizoguchi, Koichi
AU - Okamoto, Koichi
AU - Hasegawa, Kazuko
AU - Aoki, Masashi
AU - Kawata, Akihiro
AU - Abe, Koji
AU - Oda, Masaya
AU - Konagaya, Masaaki
AU - Imai, Takashi
AU - Nakagawa, Masanori
AU - Tsuji, Shoji
AU - Kaji, Ryuji
AU - Nakano, Imaharu
AU - Sobue, Gen
PY - 2013/12
Y1 - 2013/12
N2 - Objective: To clarify the emergence of muscle weakness in regions of the body that affect survival, and deterioration in activities of daily living (ADL) in amyotrophic lateral sclerosis (ALS) patients. Methods: We conducted a multicentre-based prospective cohort study of patients with ALS. We enrolled 401 sporadic patients with ALS. Death or the introduction of invasive ventilation was defined as the primary endpoint, and the time to five clinical markers of ADL deterioration associated with bulbar paralysis or limb weakness were defined as ADL milestones. Muscle weakness was assessed in the neck flexor muscles; the bilateral abductors of the shoulders; the bilateral wrist extensor muscles; the bilateral flexor muscles of the hips; and the bilateral ankle dorsi flexion muscles. We performed Cox proportional hazards regression analyses for the primary endpoint and the five ADL milestones, adjusting for known covariate prognostic factors for ALS. Results: The Medical Research Council (MRC) score for the neck flexors was the most significant prognostic factor for the primary endpoint (HR 0.74, p<0.001), loss of speech (HR 0.66, p<0.001), and loss of swallowing function (HR 0.73, p<0.001), and was one of the significant prognostic factors for loss of upper limb function, difficulty turning in bed , and loss of walking ability ( p=0.001, 0.002, and 0.008, respectively). The MRC score for the neck flexors was also a significant prognostic factor for covariates of the previously reported prognostic factors. Conclusions: Neck weakness is an independent prognostic factor for survival and deterioration in ADL in Patients with ALS.
AB - Objective: To clarify the emergence of muscle weakness in regions of the body that affect survival, and deterioration in activities of daily living (ADL) in amyotrophic lateral sclerosis (ALS) patients. Methods: We conducted a multicentre-based prospective cohort study of patients with ALS. We enrolled 401 sporadic patients with ALS. Death or the introduction of invasive ventilation was defined as the primary endpoint, and the time to five clinical markers of ADL deterioration associated with bulbar paralysis or limb weakness were defined as ADL milestones. Muscle weakness was assessed in the neck flexor muscles; the bilateral abductors of the shoulders; the bilateral wrist extensor muscles; the bilateral flexor muscles of the hips; and the bilateral ankle dorsi flexion muscles. We performed Cox proportional hazards regression analyses for the primary endpoint and the five ADL milestones, adjusting for known covariate prognostic factors for ALS. Results: The Medical Research Council (MRC) score for the neck flexors was the most significant prognostic factor for the primary endpoint (HR 0.74, p<0.001), loss of speech (HR 0.66, p<0.001), and loss of swallowing function (HR 0.73, p<0.001), and was one of the significant prognostic factors for loss of upper limb function, difficulty turning in bed , and loss of walking ability ( p=0.001, 0.002, and 0.008, respectively). The MRC score for the neck flexors was also a significant prognostic factor for covariates of the previously reported prognostic factors. Conclusions: Neck weakness is an independent prognostic factor for survival and deterioration in ADL in Patients with ALS.
UR - http://www.scopus.com/inward/record.url?scp=84888039014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888039014&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2013-306020
DO - 10.1136/jnnp-2013-306020
M3 - Article
C2 - 23933739
AN - SCOPUS:84888039014
SN - 0022-3050
VL - 84
SP - 1365
EP - 1371
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
IS - 12
ER -